Creo Medical Group Plc (CMEOF)
0.15
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Creo Medical Group Cash from Operations (TTM) : -57.78M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -57.78M |
| December 31, 2025 | -55.12M |
| June 30, 2025 | -27.06M |
| June 30, 2024 | -24.59M |
| December 31, 2023 | -25.89M |
| June 30, 2023 | -29.14M |
| December 31, 2022 | -31.27M |
| June 30, 2022 | -38.65M |
| December 31, 2021 | -35.73M |
| Date | Value |
|---|---|
| June 30, 2021 | -26.02M |
| December 31, 2020 | -21.00M |
| June 30, 2020 | -19.81M |
| December 31, 2019 | -14.73M |
| June 30, 2019 | |
| December 31, 2018 | |
| June 30, 2018 | |
| June 30, 2017 | -8.735M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Smith & Nephew plc | 1.330B |
| Convatec Group Plc | 383.49M |
| Tristel Plc | 14.21M |
| Abingdon Health Plc | -2.974M |
| Abbott Laboratories | 9.905B |